Aczone is a topical medication used to treat acne vulgaris. Its active ingredient dapsone works by inhibiting bacterial growth and reducing inflammation. It belongs to the class of antimicrobial agents known as sulfone derivatives. The gel penetrates the skin to reach the follicular environment where acne lesions develop. By decreasing the number of propionibacterium acnes bacteria the product lowers bacterial load on the skin. Simultaneously dapsone suppresses the production of inflammatory cytokines which helps to calm redness and swelling. This dual action results in clearer skin over several weeks of consistent application.

Aczone is a topical medication that contains the active ingredient dapsone in a gel formulation. It is classified as an antimicrobial and anti-inflammatory agent used in the treatment of acne. The drug works by inhibiting bacterial protein synthesis and reducing the activity of inflammatory cells in the skin. Its pharmacological properties include good penetration of the follicular canal and a low systemic absorption rate. By decreasing the population of propionibacterium acnes and modulating cytokine release, Aczone helps to clear lesions and prevent new breakouts. The anti-inflammatory effect is achieved through the downregulation of nuclear factor kappa b signaling in keratinocytes. This combined antibacterial and anti-inflammatory action provides a dual mechanism that addresses both the infectious and inflammatory components of acne.

The most common side effects include headache, nausea, fatigue, dizziness, and mild skin rash. Headache often appears early and usually resolves as the body adjusts. Nausea may occur with or without food intake. Fatigue can affect daily activities but tends to decrease over time. Dizziness is typically short lived and rarely leads to serious impairment. Mild skin rash is usually localized and clears without treatment.

The most common side effects reported with many treatments include mild headache. Patients often notice temporary fatigue that usually resolves within a day. Some individuals experience mild nausea that does not require intervention. Light dizziness can occur, especially after the first dose. Slight skin irritation may appear at the application site. Occasional changes in taste perception have been noted in clinical observations. Mild cold-like symptoms such as a runny nose are occasionally recorded. Most of these effects are short-lived and fade without specific treatment.